Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.

Schuiveling M, Ter Maat LS, Van Duin IAJ, Verheijden RJ, Troenokarso MF, Moeskops P, Verhoeff JJC, Elias SG, van Amsterdam WAC, Burgers F, Van den Berkmortel FWPJ, Boers-Sonderen MJ, Boomsma MF, De Groot JW, Haanen JBAG, Hospers GAP, Piersma D, Vreugdenhil G, Westgeest HM, Kapiteijn E, Labots M, Veldhuis WB, Van Diest PJ, De Jong PA, Pluim JPW, Leiner T, Veta M, Suijkerbuijk KPM

Open source

DOI
10.1093/jnci/djaf039
Published
2025 Jun 1
Container
Journal of the National Cancer Institute
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jnci/djaf039,
  title = {Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.},
  author = {Schuiveling M and Ter Maat LS and Van Duin IAJ and Verheijden RJ and Troenokarso MF and Moeskops P and Verhoeff JJC and Elias SG and van Amsterdam WAC and Burgers F and Van den Berkmortel FWPJ and Boers-Sonderen MJ and Boomsma MF and De Groot JW and Haanen JBAG and Hospers GAP and Piersma D and Vreugdenhil G and Westgeest HM and Kapiteijn E and Labots M and Veldhuis WB and Van Diest PJ and De Jong PA and Pluim JPW and Leiner T and Veta M and Suijkerbuijk KPM},
  year = {2025},
  journal = {Journal of the National Cancer Institute},
  doi = {10.1093/jnci/djaf039},
  url = {https://doi.org/10.1093/jnci/djaf039}
}

RIS

TY  - JOUR
TI  - Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.
AU  - Schuiveling M
AU  - Ter Maat LS
AU  - Van Duin IAJ
AU  - Verheijden RJ
AU  - Troenokarso MF
AU  - Moeskops P
AU  - Verhoeff JJC
AU  - Elias SG
AU  - van Amsterdam WAC
AU  - Burgers F
AU  - Van den Berkmortel FWPJ
AU  - Boers-Sonderen MJ
AU  - Boomsma MF
AU  - De Groot JW
AU  - Haanen JBAG
AU  - Hospers GAP
AU  - Piersma D
AU  - Vreugdenhil G
AU  - Westgeest HM
AU  - Kapiteijn E
AU  - Labots M
AU  - Veldhuis WB
AU  - Van Diest PJ
AU  - De Jong PA
AU  - Pluim JPW
AU  - Leiner T
AU  - Veta M
AU  - Suijkerbuijk KPM
PY  - 2025
JO  - Journal of the National Cancer Institute
DO  - 10.1093/jnci/djaf039
UR  - https://doi.org/10.1093/jnci/djaf039
ER  - 

APA

M, S., LS, T. M., IAJ, V. D., RJ, V., MF, T., P, M., JJC, V., SG, E., WAC, V. A., F, B., FWPJ, V. D. B., MJ, B., MF, B., JW, D. G., JBAG, H., GAP, H., D, P., G, V., HM, W., E, K., M, L., WB, V., PJ, V. D., PA, D. J., JPW, P., T, L., M, V., & KPM, S. (2025). Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study.. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf039

Source records